Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/08/2014US20140127233 Pharmaceutical composition for treating ischemic events
05/08/2014US20140127231 p38 MAPK Pathway Inhibitors as Female-Specific Therapeutics
05/08/2014US20140127228 Inhibition of tgfbeta signaling to improve muscle function in cancer
05/08/2014US20140127226 T Cell Regulation
05/08/2014US20140127224 Therapeutic Method
05/08/2014US20140127202 Antitumour combinations containing a vegf inhibiting agent and irinotecan
05/08/2014US20140127199 Compositions and methods for treating or preventing lupus
05/08/2014US20140127194 Combined pharmaceutical compositions for the treatment of tumors
05/08/2014US20140127193 Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
05/08/2014US20140127187 Targeting agent for cancer cell or cancer-associated fibroblast
05/08/2014US20140127185 Methods and compositions using neuroprotective steroids and thrombolytic agents
05/08/2014US20140127179 Natural Killer Cell Formulations
05/08/2014US20140127160 Treatment of hepatitis c virus with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha 2a/2b and ribavirin
05/08/2014US20140127159 HCV Combination Therapy
05/08/2014US20140127158 Combination therapy for hepatitis c virus infection
05/08/2014US20140127157 Antiviral activity of tyrosine kinase inhibitors against hepatitus c virus
05/08/2014US20140127156 Hepatitis C Virus Inhibitors
05/08/2014US20140127154 Pregnancy hormone combination for treatment of autoimmune diseases
05/08/2014DE102013017829A1 Verfahren zur Verabreichung eines Mittels zur Bekämpfung von Ektoparasiten bei Hunden A method for administration of an agent for controlling ectoparasites in dogs
05/08/2014DE102006053385B4 Enterococcus faecalis-Antigen Enterococcus faecalis antigen
05/07/2014EP2727996A1 Treatment of chronic inflammatory respiratory disorders with NP1 inhibitors
05/07/2014EP2727927A1 Camptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
05/07/2014EP2727926A1 Phosphoric acid ester derivative
05/07/2014EP2727921A1 2-((R)-2-methylpyrrolidin-2-YL)-1H-benzimidazole-4-carboxamide crystalline form 2
05/07/2014EP2727920A1 1,5-naphthyridine derivative or salt thereof
05/07/2014EP2727919A1 Benzocycloheptanethiophene derivatives for anti-allergic reactions
05/07/2014EP2727918A1 Compounds and Compositions as Protein Kinase Inhibitors
05/07/2014EP2727917A1 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
05/07/2014EP2727916A1 Neuroprotective multi-target directed drugs
05/07/2014EP2727915A1 Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
05/07/2014EP2727914A1 Polymorph of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-carboxamide
05/07/2014EP2727913A1 (4-Tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-N-carboxamide derivatives
05/07/2014EP2727912A1 Crystals of glycine derivative and pharmaceutical use thereof
05/07/2014EP2727911A1 Novel means and methods for treating malaria and other parasitic disorders
05/07/2014EP2727910A1 Pyridin-2-yl-thiourea and Pyridin-2-yl-amine derivatives as intermediates for the preparation of Pyridin-2yl-amino-1,2,4-thiadiazole glucokinase activators
05/07/2014EP2727909A1 Inhibitors of focal adhesion kinase
05/07/2014EP2727908A2 2,5-disubstituted arylsulfonamide CCR3 antagonists
05/07/2014EP2727626A1 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
05/07/2014EP2727604A1 Antipruritic agent
05/07/2014EP2727603A1 Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid
05/07/2014EP2727597A1 Glucose responsive hydrogel comprising pba-grafted hyaluronic acid (ha)
05/07/2014EP2727596A1 eEF2/eEF2K as therapeutic target for treating TNF-alpha-related diseases
05/07/2014EP2727595A2 Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
05/07/2014EP2727594A1 Novel pharmaceutical composition
05/07/2014EP2727593A1 Nicorandil-containing pharmaceutical composition
05/07/2014EP2727592A1 A combination of desloratadine and paracetamol
05/07/2014EP2727591A2 Stable pharmaceutical compositions containing cefaclor and clavulanic acid
05/07/2014EP2727590A1 Compositions for treating centrally mediated nausea and vomiting
05/07/2014EP2727589A1 Constitutional function-improving agents
05/07/2014EP2727588A1 Baclofen and acamprosate based therapy of neurological disorders
05/07/2014EP2727587A1 Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
05/07/2014EP2727586A1 Soyasapogenol composition
05/07/2014EP2727585A1 In-vivo screening method
05/07/2014EP2727583A2 Drug carrier and drug carrier kit for inhibiting fibrosis
05/07/2014EP2727582A1 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
05/07/2014EP2727581A1 Injectable composition combining a filling agent and a fibroblast growth medium
05/07/2014EP2727473A2 Combination of effective substances causing synergistic effects of multiple targeting and use thereof
05/07/2014EP2726869A2 Somatic mutations in atrx in brain cancer
05/07/2014EP2726612A1 Composition comprising inhibitors of irs-1 and of vegf
05/07/2014EP2726611A1 Hcv combination therapy
05/07/2014EP2726610A1 Hcv combination therapy
05/07/2014EP2726513A1 Process for preparing heparinoids and intermediates useful in the synthesis thereof
05/07/2014EP2726492A1 Selective glycosidase inhibitors and uses thereof
05/07/2014EP2726487A1 Benzopyranobenzothiazinones and their use as fungicides, antibiotics and antitumor agents
05/07/2014EP2726486A1 Novel esters of n-acylated derivatives of amino acids and isosorbide, method for preparing same, and use thereof in cosmetics and as drug
05/07/2014EP2726483A1 Novel salts of sitagliptin
05/07/2014EP2726482A1 Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors
05/07/2014EP2726479A1 Novel inhibitor compounds of phosphodiesterase type 10a
05/07/2014EP2726478A1 Oxazetidine derivatives, process for preparing them and use thereof in human medicine and in cosmetics
05/07/2014EP2726475A1 Tripeptides incorporating deuterium as inhibitors of hepatitis c virus
05/07/2014EP2726470A1 1, 2, 4 -thiadiazol- 5 -ylpiperazine derivatives useful in the treatment neurodegenerative diseases
05/07/2014EP2726469A1 Oxazepines as ion channel modulators
05/07/2014EP2726468A1 Selective glycosidase inhibitors and uses thereof
05/07/2014EP2726466A1 Fused benzoxazepinones as ion channel modulators
05/07/2014EP2726465A1 Inhibitors of lrrk2 kinase activity
05/07/2014EP2726464A1 Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders
05/07/2014EP2726463A2 Dihydropyrazoles
05/07/2014EP2726462A1 Acetone solvate of ivabradine hydrochloride
05/07/2014EP2726461A1 Method for producing fine particles of aripiprazole anhydride crystals b
05/07/2014EP2726460A1 Compounds for the treatment of addiction
05/07/2014EP2726457A1 Indoleamine derivatives for the treatment of central nervous system diseases
05/07/2014EP2726456A1 Micronized crystals of atorvastatin hemicalcium
05/07/2014EP2726106A1 A complex of amorphous tomoxiprole and cyclodextrin with fast dissolution rate and process for the preparation thereof
05/07/2014EP2726105A1 A new stable anesthetic composition for reducing skin reactions
05/07/2014EP2726100A2 Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers
05/07/2014EP2726088A1 Predictive biomarker of survival in the treatment of renal cell carcinoma
05/07/2014EP2726086A2 Compositions containing nitro fatty acids
05/07/2014EP2726084A1 Method of treating pathologic heterotopic ossification
05/07/2014EP2726083A1 Oral rehydration composition
05/07/2014EP2726082A1 Compositions for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye
05/07/2014EP2726081A2 Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
05/07/2014EP2726080A1 Alcaftadine for use in the treatment of urticaria
05/07/2014EP2726079A1 Method of administration and treatment
05/07/2014EP2726078A1 Methods for treating immune-mediated diseases of the nervous system administering a compound comprising agents that inhibit prokineticin receptors activity
05/07/2014EP2726077A2 Methods and compositions for inhibition of bone resorption
05/07/2014EP2726076A1 Combination therapy
05/07/2014EP2726075A1 Novel crystalline forms of a dipeptidyl peptidase-iv inhibitor
05/07/2014EP2726074A1 Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
05/07/2014EP2726073A1 Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases
05/07/2014EP2726072A1 Epha4 is a disease modifier in motor neuron disease
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 7860